Obesity and Metabolic Disorders

The metabolic syndrome is a condition considered by a special constellation of revocable major risk factors for cardiac disease and type 2 diabetes. The main, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which are related to weight gain, specifically intra-abdominal/ectopic fat accumulation and a large waist circumference.

Obesity is becoming a worldwide epidemic. The epidemic of obesity has been paralleled by an increase in the incidence of chronic kidney disease (CKD). Several recent epidemiologic studies have shown that obesity and the metabolic syndrome are independent predictors of CKD. The prevalence of marked obesity is increasing rapidly among adults and has more than doubled in 10 years. 61% of the adult population of the United States is overweight or obese. 

 

  • Chronic Kidney Disease
  • Cardiovascular Therapy

Related Conference of Obesity and Metabolic Disorders

March 25-26, 2024

5th Annual Conference on Diabetes

London, UK
July 11-12, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Obesity and Metabolic Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in